News Focus
News Focus
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

Re: DewDiligence post# 1572

Wednesday, 02/09/2011 3:39:01 AM

Wednesday, February 09, 2011 3:39:01 AM

Post# of 20689

If Teva and MNTA were joining forces to bring a generic Copaxone to market, success would be virtually guaranteed. Under this scenario, why would a third party want to promote branded Copaxone knowing that a substantial portion of the benefit would accrue to a generic competitor?



If the DOJ forced Teva to divest branded Copaxone to consummate the deal there would be no shortage of bidders. Hence the value of the branded. Sorry to beleaguer this worthless thread.